Date published: 2026-5-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

TRPV3 Inhibitors

TRPV3 inhibitors belong to a distinct chemical class that targets a specific receptor in the realm of cellular signaling and physiological responses. The Transient Receptor Potential Vanilloid 3 (TRPV3) receptor is a member of the transient receptor potential (TRP) ion channel family, which plays a pivotal role in detecting and responding to various environmental stimuli. TRPV3 itself is predominantly expressed in skin keratinocytes, hair follicles, and other sensory neurons, making it a significant contributor to sensory perception, skin physiology, and thermoregulation. Inhibitors of the TRPV3 receptor modulate its activity by interfering with its normal functioning. The TRPV3 receptor is primarily involved in detecting changes in temperature and noxious chemicals, contributing to the sensation of warmth and nociception. TRPV3 inhibitors exert their effects by binding to specific sites on the receptor molecule, impeding its activation and subsequent ion channel opening. This leads to a decrease in the influx of ions, such as calcium and sodium, which are critical for transmitting signals within the cell. Chemically, TRPV3 inhibitors display structural diversity, featuring distinct molecular frameworks that interact with the receptor in a unique manner. These compounds often possess lipophilic properties, aiding their penetration through cellular membranes to access the target receptor. Researchers have characterized various classes of TRPV3 inhibitors, each with its specific binding mode and potency. Understanding the mechanisms by which TRPV3 inhibitors interact with the receptor has provided valuable insights into the fundamental processes underlying sensory perception and cellular responses. Continued research in this area contributes to a deeper comprehension of the intricate signaling pathways and molecular events that govern sensory perception and thermosensation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Icilin

36945-98-9sc-201557
sc-201557A
10 mg
50 mg
$91.00
$257.00
9
(1)

Icilin is a selective agonist of TRPV3 channels, characterized by its unique ability to induce thermal hyperalgesia through specific binding interactions. It stabilizes the open conformation of the channel, enhancing cation influx and altering cellular excitability. The compound's hydrophobic regions interact favorably with lipid bilayers, affecting membrane fluidity and channel activation kinetics. Icilin's distinct molecular architecture allows for precise modulation of sensory signaling pathways, contributing to its unique physiological effects.

Ruthenium red

11103-72-3sc-202328
sc-202328A
500 mg
1 g
$188.00
$250.00
13
(1)

This is a classic non-selective TRPV3 inhibitor that has been used in research to block TRPV3-mediated responses.

HC 067047

883031-03-6sc-361204
sc-361204A
10 mg
50 mg
$217.00
$840.00
9
(1)

This is a selective TRPV3 inhibitor that has shown efficacy.

LY315920

172732-68-2sc-364528
sc-364528A
5 mg
10 mg
$315.00
$490.00
(1)

While primarily known as a phospholipase A2 inhibitor, LY315920 has also been reported to inhibit TRPV3 channels.

Lidocaine

137-58-6sc-204056
sc-204056A
50 mg
1 g
$51.00
$131.00
(0)

While primarily known as a local anesthetic, lidocaine has been reported to inhibit TRPV3 channels, contributing to its analgesic effects.

A-967079

1170613-55-4sc-363348
sc-363348A
sc-363348B
5 mg
25 mg
100 mg
$88.00
$372.00
$942.00
5
(0)

Although initially developed as a TRPA1 antagonist, A-967079 has been reported to exhibit inhibitory effects on TRPV3 as well.